Search Results 21-30 of 17208 for GLP-1 medication

  1. Lixisenatide (subcutaneous route) - Side effects & dosage - Mayo Clinic

    This medicine is a glucagon-like peptide-1 (GLP-1) receptor agonist. ... This medicine should come with a Medication ... Take birth control pills at least 1 hour ...

  2. Mayo Clinic Q & A: Supporting weight-loss medications with adequate, tailored nutrition

    Medications for obesity approved by the Food and Drug Administration often work by decreasing appetite and increasing fullness. Popular glucagon-like peptide 1 ...

  3. Management of obesity within hepatology clinics - Mayo Clinic

    Anti-obesity medications · Glucagon-like peptide 1 (GLP-1) receptor agonists. These agents can lead to significant weight loss. According to Dr. · Sodium-glucose ...

  4. Diabetes treatment disparities widespread, room for improvement

    Two diabetes prescriptions that have benefits beyond lowering blood sugar are GLP-1 receptor agonist (GLP-1RA) and SGLT2 inhibitor (SGLT2i) medications. For ...

  5. Science Saturday: Diabetes treatment disparities widespread, room for improvement - Mayo Clinic News Network

    McCoy. Two diabetes prescriptions that have benefits beyond lowering blood sugar are GLP-1 receptor agonist (GLP-1RA) and SGLT2 inhibitor (SGLT2i) medications.

  6. Examining the impact of GLP-1 receptor agonist use on quality of bowel preparation for colonoscopy - Mayo Clinic

    "These medications are known to delay gastrointestinal motility, which can adversely affect bowel preparation quality for colonoscopy," says Dr. Coelho-Prabhu.

  7. Using technology to remove barriers to bariatric surgery - Mayo Clinic

    ... medications and lifestyle interventions. The growing interest in GLP-1 RAs may be due to misperceptions about surgical risk and the fact that preparation ...

  8. A Study To Determine The Effects Of Blocking The Receptors Of GLP-1 On Appetite After Bariatric Surgery - Mayo Clinic

    By condition, treatment or drug name. Search tips. A Study To Determine The Effects Of Blocking The Receptors Of GLP-1 On Appetite After Bariatric Surgery.

  9. Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT) - Mayo Clinic

    The primary objective is to test the hypothesis that, compared with placebo, therapy with Subcutaneous (SQ) GLP-1 agonist in the post-Acute Heart Failure ...

  10. Why gastroenterologists and hepatologists should be involved in treating obesity - Mayo Clinic

    ... treatment of the gastrointestinal or liver disease. ... Incretin-modifying agents, including glucagon-like peptide-1 (GLP-1) receptor agonists, are emerging as ...